Nigel P. Minton
11Patents
4h-index
19Co-inventors
57Inventor score
Filing activity: May 22, 1995 → Dec 4, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6984513B2 | Anaerobe targeted enzyme-mediated prodrug therapy | Chemistry; Metallurgy | 74 | Expired |
| US6416754B1 | Anaerobe targeted enzyme-mediated prodrug therapy | Chemistry; Metallurgy | 35 | Expired |
| US6652849B2 | Anaerobe targeted enzyme mediated prodrug therapy | Chemistry; Metallurgy | 35 | Expired |
| US5772996A | Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax | Human Necessities | 10 | Expired |
| US7041792B2 | Type F botulinum toxin and use thereof | Chemistry; Metallurgy | 2 | Expired |
| US5695961A | Bi-functional expression system | Chemistry; Metallurgy | 1 | Expired |
| US6656718B2 | Modified carboxypeptidase enzymes and their use | Chemistry; Metallurgy | 1 | Expired |
| US10544422B2 | DNA molecules and methods | Chemistry; Metallurgy | 0 | Active |
| US9803208B2 | Conditional vectors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10183062B2 | Treatment for cancer | Chemistry; Metallurgy | 0 | Active |
| US8753846B2 | Methods of modifying nucleic acids in host cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.